Dr. Maged Answer Amine, MD

Dr. Amine practices at Houston Methodist Willowbrook Hospital in Houston, Texas, part of Houston Methodist.

Dr. Amine's NPI, 1639161011, was assigned on August 22, 2005. Dr. Amine graduated from Ain Shams University Faculty of Medicine in 1986. Dr. Amine holds Texas license K1340.

Dr. Amine's primary practice is Houston Methodist Willowbrook Hospital, at 18220 State Highway 249, Houston, TX 77070 in Harris County. The practice phone is (281) 477-1000.

Dr. Amine's primary practice is Houston Methodist Willowbrook Hospital in Houston, Texas, part of Houston Methodist. Dr. Amine is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Amine to 2 more hospitals, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amine practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Amine's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Amine is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Amine's licenses on file in 3 states: Texas, California and New Jersey.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cerebrovascular disease, chronic hypertension, coronary artery disease and deep vein thrombosis (DVT) among the conditions Dr. Amine treats.

CMS data shows 4,628 Medicare services from Dr. Amine across 37 procedure codes in 2024, for 1,192 Medicare patients. Medicare paid $354,339 for them.

CMS counts 1,192 Medicare patients who saw Dr. Amine in 2024. The largest group is 65 to 74, with 517 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amine's median patient age at 74, with 51% women.

In 2024, Dr. Amine wrote 5,362 Medicare Part D claims for 861 patients. 84% of them were for generic drugs. CMS names the drug for 5,135 of them, across 52 drugs with 11 or more claims each, at $750,087 in total drug cost. In 2023, CMS named 5,183 claims across 52 drugs.

Dr. Amine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of coronary angioplasty and stenting by Dr. Amine, more than 68% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,094 general payments to Dr. Amine from 70 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 37% of the total. Novartis Pharmaceuticals Corporation paid the most, $29,639.

Dmand AI lists 2 awards for Dr. Amine, most recently CMS Stage 1 EHR in 2013.

Dr. Amine graduated from Ain Shams University Faculty of Medicine in 1986. Dr. Amine is a member of ACC.

Dr. Amine is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.